Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Free vaccines: will national insurance get more people vaccinated?

NCT ID NCT07243236

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study in France tests whether having the national health insurance pay for vaccines during outpatient visits increases how many people get vaccinated. Researchers will compare vaccination rates for pneumococcal infections and whooping cough (pertussis) before and after the funding change. About 2,920 patients and healthcare providers will answer questionnaires to track the impact.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that covering vaccine costs through national insurance increases vaccination rates, helping public health officials design better funding programs.
What could go wrong
This is an observational study, not a treatment trial. It measures current practices, so it cannot prove cause and effect. Results may not apply outside France or to other vaccines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,920 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

During a follow-up hospital consultation, for patients eligible for pneumococcal vaccination or for postpartum women eligible for pertussis vaccination during pregnancy, the healthcare professional proposes and completes a questionnaire with the patient during the consultation.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For patients: 1. For the assessment of pneumococcal coverage among patients eligible for this vaccination: * Individuals aged 18 years or older, * Individuals followed in outpatient consultations within a department and healthcare institution participating in the project; * Individuals eligible for pneumococcal vaccination against according to current French recommendations, * Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME). 2. For the assessment of pertussis vaccination among pregnant women: * Women aged 18 years or older, * Women who have had at least one follow-up outpatient consultation from 20 weeks of gestation in a maternity ward participating in the project, * Women in the immediate postpartum period (during their maternity stay) who have given birth to one or more live children and delivered after 36 weeks of gestation, * Women who have declared their pregnancy and are covered under maternity insurance (i.e., from the first day of the sixth month of pregnancy until the 12th day after delivery). For healthcare professionals: all vaccinating healthcare providers working in a participating department or center. Exclusion Criteria: * Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthcare providers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthcare providers Postpartum

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • COCHIN HOSPITAL - Assistance Publique-Hôpitaux de Paris (APHP)

    RECRUITING

    Paris, IDF, 75014, France

  • Delafontaine Hospital

    NOT_YET_RECRUITING

    Saint-Denis, 93200, France

  • Rambouillet Hospital

    NOT_YET_RECRUITING

    Rambouillet, 78120, France

  • Sud Seine Et Marne Hospital

    NOT_YET_RECRUITING

    Fontainebleau, 77300, France

  • Sud Seine Et Marne Hospital

    NOT_YET_RECRUITING

    Montereau-Fault-Yonne, 77130, France

  • Sud Seine Et Marne Hospital

    NOT_YET_RECRUITING

    Nemours, 77140, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.